<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04083339</url>
  </required_header>
  <id_info>
    <org_study_id>AT-001-2001</org_study_id>
    <nct_id>NCT04083339</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy</brief_title>
  <official_title>Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure (ARISE-HF): A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Applied Therapeutics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Applied Therapeutics, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety&#xD;
      and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of&#xD;
      progression to overt heart failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study consists of two consecutive parts: Part A and Part B. Part A will evaluate the&#xD;
      safety and efficacy of two doses of AT-001 vs placebo. The primary objective of Part A is to&#xD;
      demonstrate that AT-001 improves or prevents the decline of functional capacity in patients&#xD;
      with Diabetic Cardiomyopathy. Part B is an extension of at least 12 months that will evaluate&#xD;
      the safety and efficacy of chronic administration of AT-001 vs placebo in the same patients&#xD;
      who had previously been evaluated in Part A. Assessments in Part B will include safety&#xD;
      endpoints and exploratory clinical efficacy endpoints, i.e. death and hospitalization due to&#xD;
      a cardiac event.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2019</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak VO2 during cardio-pulmonary exercise test (CPET);</measure>
    <time_frame>15 months after randomization]</time_frame>
    <description>Changes in Peak VO2 during cardio-pulmonary exercise test (CPET) from baseline to approximately Month 15 (15-18 months). A CPET may be repeated at approximately Month 27 (27-30 months).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression to overt heart failure (Stage C Heart Failure)</measure>
    <time_frame>27 months after randomization</time_frame>
    <description>Defined by the occurrence of one of the following events: cardiovascular death, hospitalization for heart failure, urgent heart failure visit, new diagnosis of heart failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in NT-proBNP</measure>
    <time_frame>27 months after randomization</time_frame>
    <description>Changes in NT-proBNP may reflect worsening of cardiomyopathy over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the modified Kansas City Cardiomyopathy Questionnaire (KCCQ) score</measure>
    <time_frame>27 months after randomization</time_frame>
    <description>Changes in the modified KCCQ may reflect deterioration of clinical status over time</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Worsening of diabetic cardiomyopathy</measure>
    <time_frame>15 and 27 months after randomization</time_frame>
    <description>Defined by either ≥ 20% increase in NT-proBNP or ≥ 5 point decrease in the mKCCQ score</description>
  </other_outcome>
  <other_outcome>
    <measure>Changes in echocardiographic parameters</measure>
    <time_frame>27 months after randomization</time_frame>
    <description>Changes assessed on cardiac ultra-sound from baseline</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">675</enrollment>
  <condition>Diabetic Cardiomyopathies</condition>
  <arm_group>
    <arm_group_label>AT-001 High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The total daily doses will be of 3g. The dose selection and the frequency of dosing was based on the results of the phase 1/2 study demonstrating that 3g/day of AT-001 is capable of producing the maximum inhibition of the production of sorbitol (a pharmacodynamic biomarker of biological activity).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AT-001 Low Dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The total daily doses will be of 2g. The dose selection and the frequency of dosing was based on the results of the phase 1/2 study demonstrating that 2g/day of AT-001 is capable of producing a sufficient inhibition of the production of sorbitol (a pharmacodynamic biomarker of biological activity).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules will be used as comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AT-001</intervention_name>
    <description>AT-001 will be administered as 3 capsules twice daily, before breakfast and before dinner.&#xD;
At present AT001 is the sole name for the active substance. No INN/genetic name is available to date</description>
    <arm_group_label>AT-001 High dose</arm_group_label>
    <arm_group_label>AT-001 Low Dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Matching placebo will be administered as 3 capsules twice daily, before breakfast and before dinner</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 2 Diabetes Mellitus&#xD;
&#xD;
          -  Echocardiographic demonstration of diabetic cardiomyopathy&#xD;
&#xD;
          -  Peak VO2 &lt; 75% of predicted normal value based on age and gender&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prior diagnosis or signs/symptoms of overt/symptomatic heart failure / stage C heart&#xD;
             failure&#xD;
&#xD;
          -  Prior echocardiogrphic measurement of ejection fraction (EF) &lt; 40%&#xD;
&#xD;
          -  Prior acute coronary syndrome (ACS), coronary artery bypass graft (CABG), percutaneous&#xD;
             coronary intervention (PCI), coronary artery disease (CAD) or stroke&#xD;
&#xD;
          -  Severe or moderate cardiac valve disease requiring intervention&#xD;
&#xD;
          -  Clinically significant arrhythmia&#xD;
&#xD;
          -  Prior diagnosis of congenital, infective, toxic, infiltrative, post-partum, or&#xD;
             hypertrophic cardiomyopathy&#xD;
&#xD;
          -  Blood pressure &gt; 140 mmHg (systolic) or &gt; 90 mmHg (diastolic) at screening&#xD;
&#xD;
          -  HbA1c &gt;8.5% at screening&#xD;
&#xD;
          -  Severe disease that would impact the performance of a cardio-pulmonary exercise test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James L Januzzi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Harvard Medical School (HMS and HSDM)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Riccardo Perfetti, MD, PhD</last_name>
    <phone>212-220-9227</phone>
    <email>rperfetti@appliedtherapeutics.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francesca Lawson, MD, FAHA</last_name>
    <phone>212-220-9256</phone>
    <email>flawson@appliedtherapeutics.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Westside Medical Associates of Los Angeles</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norman Lepor, MD</last_name>
      <phone>310-289-9955</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California, San Diego (UCSD)</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pam Taub, MD</last_name>
      <phone>858-249-1308</phone>
      <email>ptaub@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Trials Research</name>
      <address>
        <city>Lincoln</city>
        <state>California</state>
        <zip>95648</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Wayne, MD</last_name>
      <phone>916-434-8230</phone>
      <email>jwaynemd@ctrsites.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California - Irvine Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Lombardo, DO, MS</last_name>
      <phone>714-456-5376</phone>
      <email>Lombardo@uci.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Metabolic Institute of America</name>
      <address>
        <city>Tarzana</city>
        <state>California</state>
        <zip>91356</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yehuda Handelsman, MD</last_name>
      <phone>818-708-9942</phone>
      <email>Yhandelsman@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90509</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William French, MD</last_name>
      <phone>310-222-1202</phone>
      <email>wjfrench@ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ALL Medical Research, LLC</name>
      <address>
        <city>Cooper City</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Lorena Lewy-Alterbaum, MD</last_name>
      <phone>754-263-2001</phone>
      <email>drlewy@allmedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Generation of Medical Research</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karelia Ruiz, MD</last_name>
      <phone>305-828-9100</phone>
      <email>kareliar@ngmresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Broward Research Center</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Londono, MD</last_name>
      <phone>954-482-4290</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Progressive Medical Research</name>
      <address>
        <city>Port Orange</city>
        <state>Florida</state>
        <zip>32127</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander White, MD</last_name>
      <phone>386-304-7070</phone>
      <email>dralexwhite@progressivemedicalresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UnityPoint Health - Methodist Hospital</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Trachtenbarg, MD</last_name>
      <phone>309-672-4543</phone>
      <email>David.Trachtenbarg@Unitypoint.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanita Aroda, MD</last_name>
      <phone>617-277-1568</phone>
      <email>varoda@bwh.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universty of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lampros Papadimitrou, MD</last_name>
      <phone>601-815-4468</phone>
      <email>LPapadimitrou@umc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Louis Heart and Vascular Cardiology</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harvey Serota, MD</last_name>
      <phone>314-741-0911</phone>
      <email>hserota@slhv.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chear Center LLC</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Bernard, MD</last_name>
      <phone>347-270-1111</phone>
      <email>david@chearcenter.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leandro Slipczuk, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjeeb Bhattacharya, MD</last_name>
      <phone>216-402-8220</phone>
      <email>bhattas3@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Remington Davis, Inc.</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward Cordasco Jr, DO, FCCP</last_name>
      <phone>614-487-2560</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Oklahoma Heart Research</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73135</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naeem Tahirkheli, MD</last_name>
      <phone>405-628-3800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mountain View Clinical Research - Greer</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald K Mayfield, MD</last_name>
      <phone>864-334-0141</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mountain View Clinical Research</name>
      <address>
        <city>Greer</city>
        <state>South Carolina</state>
        <zip>29651</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Mayfield</last_name>
      <phone>864-334-0141</phone>
      <email>rmayfield@mvcresearch.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holston Medical Group</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Morawski, MD</last_name>
      <phone>423-392-6200</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dallas Diabetes Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julio Rosenstock, MD</last_name>
      <phone>972-566-7799</phone>
      <email>juliorosenstock@dallasdiabetes.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southwest Family Medicine Associates</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chrisette Dharma, MD</last_name>
      <phone>214-393-2940</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ambarish Pandey, MD</last_name>
      <phone>214-645-2010</phone>
      <email>ambarish.pandey@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Juno Research, LLC - Northwest Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Damaris Vega</last_name>
      <phone>281-880-4548</phone>
      <email>Damaris_vega@junoresearch.us</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Juno Research, LLC - Southwest Houston Site</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Lacour</last_name>
      <phone>713-779-5494</phone>
      <email>audrey_lacour@junoresearch.us</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>FMC Science</name>
      <address>
        <city>Lampasas</city>
        <state>Texas</state>
        <zip>76550</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Cain III, MD</last_name>
      <phone>512-556-4130</phone>
      <email>jecain@fmcscience.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince Charles Hospital</name>
      <address>
        <city>Chermside</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott McKenzie, FRACP, BMBS</last_name>
      <phone>+ 61 7 3139 5566</phone>
      <email>Scott.McKenzie@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CORE Research Group Pty. Ltd.</name>
      <address>
        <city>Milton</city>
        <state>Queensland</state>
        <zip>4064</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Colquhoun, MBBS, FRACP</last_name>
      <email>DColquhoun@uq.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AusTrials</name>
      <address>
        <city>Taringa</city>
        <state>Queensland</state>
        <zip>4068</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Munro Neville, MBBS, MRACGP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tasmania at Hobart</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7001</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark R Nelson</last_name>
      <phone>+61 (0)3 6226 4734</phone>
      <email>Mark.Nelson@utas.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barwon Health-University Hospital Geelong</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <zip>3220</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John V Amerena, MBBS</last_name>
      <phone>03 4215 1025</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elif Ekinci, MBBS, FRACP</last_name>
      <phone>(03) 9496 2250</phone>
      <email>elif.ekinci@unimelb.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baker Heart and Diabetes Institute</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Marwick, MBBS, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baker Heart and Diabetes Institute</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Reutens, MBBS, FRACP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>C-Endo - Endocrinology Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2V 4J2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sue Pedersen, MD, FRCPC</last_name>
      <phone>403 705-3636</phone>
      <email>drsuepedersen@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BC Diabetes</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Y 3W2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas G Elliott</last_name>
      <phone>604 683-3734</phone>
      <email>telliott@bcdiabetes.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology Ltd. - Brampton</name>
      <address>
        <city>Brampton</city>
        <state>Ontario</state>
        <zip>L6S 0C6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harpreet Bajaj, MBBS, MPH</last_name>
      <phone>905 595-0560</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology Ltd. - Thornhill</name>
      <address>
        <city>Concord</city>
        <state>Ontario</state>
        <zip>L4K 4M2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Goldenberg, MD, FRCPC</last_name>
      <phone>905 763-8660</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology Ltd. - Etobicoke</name>
      <address>
        <city>Etobicoke</city>
        <state>Ontario</state>
        <zip>M9R 4E1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hasnain Khandwala, MBBS, FRCPC</last_name>
      <phone>416 645-1035</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre for Studies in Family Medicine, Western Centre for Public Health and Family Medicine, Western University</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6G 2M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stewart Harris, MD, MPH</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>LMC Diabetes &amp; Endocrinology Ltd. - Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4G 3E8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Abitbol, MDCM, FRCPC</last_name>
      <phone>416 645-2929</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ecogene-21</name>
      <address>
        <city>Chicoutimi</city>
        <state>Quebec</state>
        <zip>G7H 7K9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Gaudet, MD, CSPQ</last_name>
      <phone>418 545-1252</phone>
      <email>daniel.gaudet@umontreal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire de Cardiologie et de Pneumologie De Quebec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Poirier, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Edumed s.r.o.</name>
      <address>
        <city>Jaroměř</city>
        <zip>55101</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiri Vesely, MD</last_name>
      <phone>+420 731 447 001</phone>
      <email>vesely.edumed@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemocnice Pardubickeho kraje, a.s., Nemocnice Pardubice</name>
      <address>
        <city>Pardubice</city>
        <zip>532 03</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karel Blaha, MD</last_name>
      <phone>+420 608 061 838</phone>
      <email>karel.blaha@nempk.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vseobecna fakultni nemocnice v Praze</name>
      <address>
        <city>Praha</city>
        <zip>128 08</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Flekac, MD, PhD</last_name>
      <phone>+420 736 204 140</phone>
      <email>milan.flekac@vfn.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean-Verdier - AP-HP; Service Endocrinologie Diabétologie Nutrition</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Valensi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Henri Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Genevieve Derumeaux, MD. PhD</last_name>
      <phone>+ 33 0603613517</phone>
      <email>genevieve.derumeaux@inserm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes, Clinique d'Endocrinologie</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samy Hadjadj, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valenciennes</name>
      <address>
        <city>Valenciennes</city>
        <zip>59322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hatem Boughanmi, MD</last_name>
      <phone>+336 077049 75</phone>
      <email>Boughanmi-h@ch-valenciennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt (Oder) GmbH</name>
      <address>
        <city>Frankfurt (Oder)</city>
        <state>Brandenburg</state>
        <zip>15236</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kilian Rittig, MD</last_name>
      <phone>+49 335 548 4680</phone>
      <email>kilian.rittig@klinkumffo.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz-und Diabeteszentrum NRW Universitaetsklinik der Ruhr-Universitaet Bochum</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>North Rhine Westphalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Hee Lee Barkey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cardiologicum Pirna und Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxony</state>
        <zip>01277</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Axthelm, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinische Forschung Berlin GbR</name>
      <address>
        <city>Berlin</city>
        <zip>10787</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Schenkenberger</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZKS - Zentrum Klinische Studien Sudbrandenburg GmbH</name>
      <address>
        <city>Elsterwerda</city>
        <zip>04910</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Hagenow, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erik Yee Mun George Fung</name>
      <address>
        <city>Sha Tin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Yee Mun George Fung, DABIM, FACC</last_name>
      <phone>+852 3505 3140</phone>
      <email>e.fung@cuhk.edu.hk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital; Chinese University of Hong Kong; Dept of Medicine and Therapeutics</name>
      <address>
        <city>Sha Tin</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juliana Chan, MD, FRCP</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Chorob Serca w USK</name>
      <address>
        <city>Wrocław</city>
        <state>Borowska</state>
        <zip>50-556</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanna Szachniewicz, MD</last_name>
      <phone>0048 71-736-42-76</phone>
      <email>JSzachniewicz@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny</name>
      <address>
        <city>Białystok</city>
        <zip>15-435</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Arciszewska</last_name>
      <phone>+48 (85) 664 40 50</phone>
      <email>Malgorzata@Arciszewska.eu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Topolowa MEDICENTER Mrózek &amp; wspólnicy sp.j.</name>
      <address>
        <city>Kraków</city>
        <zip>31-506</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michal Terlecki, MD. PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Twojego Zdrowia</name>
      <address>
        <city>Kraków</city>
        <zip>31-526</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcin Nosal, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praktyka Lekarska Ewa Krzyzagorska</name>
      <address>
        <city>Poznań</city>
        <zip>61-655</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewa Krzyzagorska, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prywatny Gabinet Lekarski Centrum Medyczne Diabetika</name>
      <address>
        <city>Radom</city>
        <zip>26-600</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorota Mlodawska-Choluj</last_name>
      <phone>+48 48 331 02 16</phone>
      <email>choluj@ra.home.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Medyk Stanislaw Mazur Sp. z o.o. SK</name>
      <address>
        <city>Rzeszów</city>
        <zip>35-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislaw Mazur, MD, MBBS</last_name>
      <phone>+48 501 427 278</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>4 Wojskowy Szpital Kliniczny z Poliklinika Samodzielny Publiczny ZOZ we Wroclawiu</name>
      <address>
        <city>Wrocław</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bartosz Krakowiak, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ETG Lodz</name>
      <address>
        <city>Łódź</city>
        <zip>90-302</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Mordaka</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Alonso, MD, PhD</last_name>
      <phone>+34 934 978 860</phone>
      <email>nalonso32416@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domingo Pascual Figal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Abente y Lago (Complejo Universitario de la Coruña)</name>
      <address>
        <city>A Coruña</city>
        <zip>15001</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Luis Diaz Diaz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Perez, MD</last_name>
      <phone>+34 935 565 657</phone>
      <email>aperez@sanpau.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Reina Sofia</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Delgado Lista, MD. PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafael Jesus Hidalgo Urbano, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julio Nuñez de Villota, MD, PhD</last_name>
      <phone>+34 961 97 35 20</phone>
      <email>yulnunez@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ninewells Hospital &amp; Medical School</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chim Lang, MD FRCP</last_name>
      <phone>01382 660111</phone>
      <email>c.c.lang@dundee.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CPS Research</name>
      <address>
        <city>Glasgow</city>
        <zip>G20 0XA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Baranowski, MRCGP, GMC</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glenfield hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerald McCann</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barts and The London School of Medicine &amp; Dentistry</name>
      <address>
        <city>London</city>
        <zip>EC1M 6BQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manish Saxena, GMC</last_name>
      <phone>020 7882 3856</phone>
      <email>m.saxena@qmul.ac.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <zip>M23 9Lt</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Basil Issa, MD, FRCP</last_name>
      <phone>0161 291 2399</phone>
      <email>basil.issa@uhsm.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 23, 2019</study_first_submitted>
  <study_first_submitted_qc>September 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2019</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 2 Diabetes</keyword>
  <keyword>Aldose Reductase Inhibitor</keyword>
  <keyword>Stage B Heart Failure</keyword>
  <keyword>Stage C Heart Failure</keyword>
  <keyword>Cardiopulmonary Exercise Test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Diabetic Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

